IE 11 is not supported. For an optimal experience visit our site on another browser.
  • UP NEXT

    Hannah Waddingham on ‘The Fall Guy’ and impact of ‘Ted Lasso’

    08:29
  • Kevin Bacon shares reality check from student at ‘Footloose’ school

    00:40
  • Caitlin Clark to reportedly sign 8-figure deal with Nike

    04:33
  • NASA graduates new astronauts for Orion capsule mission

    03:23
  • Carl Erskine, legendary Dodgers pitcher, dies at 97

    02:23
  • US airman marks last day in Kuwait with Sunday Mug Shot

    01:07
  • Sports league scandals highlight risks of gambling

    04:50
  • What to expect as Trump’s historic criminal hush money trial begins

    02:01
  • House passes bill that could ban TikTok in the US

    02:01
  • Will US aid be enough to help Ukraine win Russia’s war?

    01:48
  • House passes foreign aid bill for Ukraine, Israel and Taiwan

    02:11
  • Alicia Keys talks Broadway show inspired by her life and career

    07:47
  • How the O.J. Simpson case captivated Americans

    03:55
  • Trina Robbins, comic book creator and historian, dies at 85

    01:53
  • Science class of ’78 reunites for solar eclipse in Sunday Mug Shot

    01:49
  • How will voters react to Trump’s criminal hush money trial?

    02:02
  • Trump rallies supporters in Pennsylvania ahead of hush money trial

    01:46
  • Could Iran’s attack on Israel lead to wider war in Middle East?

    02:11
  • Biden tells Israel that US won’t support counterattack on Iran

    01:39
  • Israel blocks Iran drone attack with help of US and allies

    02:07

New drugs revolutionizing weight-loss and health care

04:34

The FDA has approved Zepbound, the latest in a growing number of drugs that are revolutionizing weight loss as America faces an epidemic of obesity. Will insurance companies begin to cover the cost and are doctors sure they are safe? NBC’s Liz Kreutz reports in this week’s Sunday Focus. **CORRECTION: An earlier version of this story incorrectly stated that Eli Lilly’s Mounjaro has only been approved for people with pre-diabetes. It has now been updated to reflect that Mounjaro has been approved for people with pre-diabetes and Type 2 diabetes.**